A single histrelin implant is effective for 2 years for treatment of central precocious puberty

Katherine A. Lewis, Andrea K. Goldyn, Karen W. West, Erica A. Eugster

Research output: Contribution to journalArticle

28 Scopus citations


We investigated whether a "yearly" histrelin implant would provide pubertal suppression when left in place for 2 years. Equivalent suppression was observed when comparing 12 and 24 months in 33 children with central precocious puberty. A single implant for 2 years reduces cost and number of implant procedures.

Original languageEnglish (US)
Pages (from-to)1214-1216
Number of pages3
JournalJournal of Pediatrics
Issue number4
StatePublished - Oct 1 2013


ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this